ENDONOVO THERAPEUTICS, INC. (ENDV) Operating income 2013–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) annual operating income history from SEC filings — each fiscal year as reported.
-$3.3MFY2022 · since FY2013: -$2.4M → -$3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$3.3M | -46.6% |
| FY2021 | -$2.2M | +23.5% |
| FY2020 | -$2.9M | +23.5% |
| FY2019 | -$3.8M | +8.4% |
| FY2018 | -$4.2M | +9.7% |
| FY2017 | -$4.6M | +14.9% |
| FY2016 | -$5.4M | -111.0% |
| FY2015 | -$2.6M | -17.0% |
| FY2014 | -$2.2M | +9.8% |
| FY2013 | -$2.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice